The Incidence and Clinical Significance of the Micrometastases in the Sentinel Lymph Nodes During Surgical Staging for Early Endometrial Cancer

被引:21
作者
Ferraioli, Domenico [1 ]
Chopin, Nicolas
Beurrier, Frederic
Carrabin, Nicolas
Buenerd, Annie [2 ]
Mathevet, Patrice [1 ,2 ]
机构
[1] Femme Mere Enfant Hosp, Dept Gynecol, Lyon, France
[2] Univ Lausanne, Dept Gynecol, Lausanne, Switzerland
关键词
Early endometrial cancer; Sentinel lymph nodes; Micrometastases; Prognosis factors; ACCURACY; BIOPSY; METASTASIS; PREDICTION; INJECTION; PATTERNS; INVASION;
D O I
10.1097/IGC.0000000000000408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction The status of regional node remains one of the most important factors to guide adjuvant therapy in endometrial cancer (EC). Pelvic recurrence occurs in up to 15% of early EC patients with negative pelvic lymph nodes (LNs). The prognostic significance of detecting micrometastases (M) in LN is debated. This retrospective case-control study performed in the Oncological Gynecology Department in Lyon between December 1998 and June 2012 reports the incidence and the clinical significance of M detected during ultrastaging of negative sentinel lymph node (SLN) in EC. Patients and Methods Ninety-three patients affected by type I and II EC were submitted to surgery with SLN. Dual-labeling method was used to detect SLN. All the SLNs were subjected to ultrastaging researching M. The patients with a locoregional or distant relapse represented the case-series (CS). The patients without locoregional or distant recurrences were the case-controls (CC).They were matched (1:2 ratio) according to age, International Federation of Gynecology and Obstetrics stage, and histopathologic features. Results Ten patients presenting a relapse represented CS. In the remaining 83 patients without recurrence, 20 CC were individualized. The detection rate of SLN per hemipelvis was of 17 (85%) of 20 hemipelvis and of 33 (82.5%) of 40 hemipelvis for CS and CC, respectively. Two SLN of CS arm were positives at frozen section. One of the 8 patients of CS arm with negative SLNs was positive for M by immunohistochemistry analysis. Conclusions Lymph node status is one of the most important histopathologic features to determine the adjuvant treatment. The SLN technique could be proposed in selected patients affected by early EC. The M in SLN could be researched and could help to modulate the following treatment. The multicenter study must be performed to clarify the optimal method of research of SLN in EC and the significance of M in the LN.
引用
收藏
页码:673 / 680
页数:8
相关论文
共 31 条
  • [1] Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center
    Abu-Rustum, Nadeem R.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (02) : 327 - 334
  • [2] Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?
    Abu-Rustum, Nadeem R.
    Iasonos, Alexia
    Zhou, Qin
    Oke, Eniola
    Soslow, Robert A.
    Alektiar, Kaled M.
    Chi, Dennis S.
    Barakat, Richard R.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04) : 457.e1 - 457.e6
  • [3] Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
    Abu-Rustum, Nadeem R.
    Khoury-Collado, Fady
    Pandit-Taskar, Neeta
    Soslow, Robert A.
    Dao, Fanny
    Sonoda, Yukio
    Levine, Douglas A.
    Brown, Carol L.
    Chi, Dennis S.
    Barakat, Richard R.
    Gemignani, Mary L.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (02) : 163 - 169
  • [4] Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer
    AlHilli, M. M.
    Podratz, K. C.
    Dowdy, S. C.
    Bakkum-Gamez, J. N.
    Weaver, A. L.
    McGree, M. E.
    Keeney, G. L.
    Cliby, W. A.
    Mariani, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 103 - 108
  • [5] A suggested modification to FIGO stage I endometrial cancer
    Aristizabal, Patrick
    Graesslin, Olivier
    Barranger, Emmanuel
    Clavel-Chapelon, Francoise
    Haddad, Bassam
    Luton, Dominique
    Darai, Emile
    Rouzier, Roman
    Koskas, Martin
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 192 - 196
  • [6] Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)
    Ballester, Marcos
    Dubernard, Gil
    Lecuru, Fabrice
    Heitz, Denis
    Mathevet, Patrice
    Marret, Henri
    Querleu, Denis
    Golfier, Francois
    Leblanc, Eric
    Rouzier, Roman
    Darai, Emile
    [J]. LANCET ONCOLOGY, 2011, 12 (05) : 469 - 476
  • [7] Ultrastaging of lymph node in uterine cancers
    Bezu, Corinne
    Coutant, Charles
    Ballester, Marcos
    Feron, Jean-Guillaume
    Rouzier, Roman
    Uzan, Serge
    Darai, Emile
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [8] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Colombo, N.
    Preti, E.
    Landoni, F.
    Carinelli, S.
    Colombo, A.
    Marini, C.
    Sessa, C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 33 - 38
  • [9] Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer
    Delaloye, Jean-Francois
    Pampallona, Sandro
    Chardonnens, Eric
    Fiche, Maryse
    Lehr, Hans-Anton
    De Grandi, Pierre
    Delaloye, Angelika Bischof
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 89 - 93
  • [10] Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases
    Delpech, Yann
    Coutant, Charles
    Darai, Emile
    Barranger, Emmanuel
    [J]. SURGICAL ONCOLOGY-OXFORD, 2008, 17 (03): : 237 - 245